MERS-CoV S
Origine: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hôte: Escherichia coli (E. coli)
Recombinant
>95% pure as determined by 12% PAGE (coomassie staining).
MERS-Coronavirus Spike (MERS-CoV S)
(MERS-Coronavirus Spike Protein (MERS-CoV S))
Type de proteíne
Recombinant
Origine
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Source
Escherichia coli (E. coli)
Attributs du produit
Recombinant SARS MERS Spike S1 is a peptide from amino acids 56-295 of spike protein S1 produced in E. coli and fused to a 6xHis tag at its C-terminus (UniProt accession #AHC74088).SARS MERS is purified by a proprietary chromatographic technique.
Pureté
>95% pure as determined by 12% PAGE (coomassie staining).
MERS-CoV S
Origine: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hôte: Baculovirus infected Insect Cells
Recombinant
> 85 % as determined by SDS-PAGE
Active
MERS-CoV S
Origine: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hôte: Baculovirus infected Insect Cells
Recombinant
> 90 % as determined by SDS-PAGE
Active
MERS-CoV S
Origine: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hôte: HEK-293 Cells
Recombinant
> 95 % as determined by SDS-PAGE. > 95 % as determined by SEC-HPLC.
Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom,